SCHEMBL27768102

SCHEMBL27768102

COc1cccc(-c2ccccc2OC(N)=O)n1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.50
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
TGFBR2 P37173 1/20 0.43
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
BTK Q06187 1/20 0.40
ATP4A P20648 2/20 0.39
ATP4B P51164 2/20 0.39
IKBKB O14920 1/20 0.39
PARP1 P09874 1/20 0.39
PDE10A Q9Y233 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
NNMT P40261 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27768368 0.83 F10 (0.47)
SCHEMBL27747197 0.82 ALDH1A1 (0.40) TGFBR1ALDH1A1HPGDATP4AATP4B
SCHEMBL27747194 0.79 ALDH1A1 (0.43) TGFBR1ALDH1A1HPGDPARP1ADORA3
SCHEMBL8626884 0.78 NPSR1 (0.45) ALDH1A1IKBKBADORA3
SCHEMBL10989255 0.77 ALDH1A1 (0.46) ALDH1A1HPGDHSP90AA1HSP90AB1ATP4A
SCHEMBL4083577 0.76 CA12 (0.50) ALDH1A1HPGDIKBKB
SCHEMBL27768099 0.75 PARP1 (0.48) TGFBR1TGFBR2BTKPARP1ADORA3
SCHEMBL1952638 0.75 MEN1 (0.46) ALDH1A1HPGD
SCHEMBL4705063 0.74 GRM4 (0.48) TGFBR1ALDH1A1ADORA3
SCHEMBL28732669 0.74 MAPT (0.44) ALDH1A1HSP90AA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466710-B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC 2013-05-29 CN disclosed
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed